Table 2.
Baseline data per nodule.
| Number n = 280 (percent) | Local recurrence/nodule (percent) | |
|---|---|---|
| Sex | ||
| Male | 183 (65.36%) | 7 (7/183 = 3.83%) |
| Female | 97 (34.64%) | 2 (2/97 = 2.06%) |
| R status | ||
| R0 | 217 (77.50%) | 5 (5/217 = 2.30%) |
| Rx | 63 (22.50%) | 4 (4/63 = 6.34%) |
| Size | ||
| < 12 mm | 188 (67.14%) | 3 (3/188 = 1.59%) |
| ≥ 12 mm | 92 (32.85%) | 6 (6/92 = 6.52%) |
| Spread of the disease | n = 268 | |
| Bilateral disease | 203 (75.74%) | 7 (7/203 = 3.44%) |
| Ipsilateral disease | 65 (24.25%) | 2 (2/65 = 3.07%) |
| Location | ||
| UL | 108 (38.57%) | 4 (4/108 = 3.70%) |
| ML | 31 (11.07%) | 1 (1/31 = 3.22%) |
| LL | 141 (50.35%) | 4 (4/141 = 2.83%) |
| Total | 280 | 9 (9/280 = 3.21%) |
UL, Upper lobe; ML, middle lobe; LL, lower lobe.